Vasculogenic Erectile Dysfunction Clinical Trial
Official title:
A Prospective, Randomized, Double Blind With Sham Control, Clinical Study to Assess the Safety and Efficacy of Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' in Patients With Erectile Dysfunction
This is a prospective, randomized, double-blind clinical study for assessing the safety and efficacy of the treatments performed with Renova (LI-ESWT) on symptomatic ED patients.
This is a prospective, randomized, double-blind clinical study comparing safety and efficacy of the treatments performed with Renova (LI-ESWT) on symptomatic ED patients to the safety and efficacy of the control sham patients. Patients are randomized in a 1:1 ratio of Renova to the sham control group. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02584686 -
Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction
|
Phase 1 | |
| Terminated |
NCT01811797 -
Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova
|
N/A | |
| Completed |
NCT02005731 -
Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction
|
N/A | |
| Terminated |
NCT02152683 -
Linear Focused Shockwave Treatment for Erectile Dysfunction
|
N/A | |
| Withdrawn |
NCT03843086 -
Low Intensity Linear Shockwave Therapy for Erectile Dysfunction
|
N/A | |
| Completed |
NCT03067987 -
Safety and Efficacy of Low Intensity Shockwave for the Treatment of Erectile Dysfunction
|
N/A |